Share Price and Basic Stock Data
Last Updated: January 3, 2026, 12:30 pm
| PEG Ratio | -4.13 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Sudarshan Chemical Industries Ltd operates in the Dyes & Pigments sector, where it reported a market capitalization of ₹7,546 Cr and a share price of ₹960. The company has demonstrated a notable increase in revenue over recent years, with sales rising from ₹2,201 Cr in FY 2022 to ₹2,302 Cr in FY 2023, and projected to reach ₹3,346 Cr in FY 2025. This upward trajectory in revenue reflects an annual growth rate, with trailing twelve months (TTM) sales standing at ₹6,910 Cr. Quarterly sales figures illustrate fluctuations, with a peak of ₹764 Cr recorded in March 2024, followed by ₹1,349 Cr in March 2025. The company’s ability to maintain steady sales figures amidst market challenges is indicative of its operational resilience and market positioning.
Profitability and Efficiency Metrics
The profitability of Sudarshan Chemical Industries is characterized by a low operating profit margin (OPM) of 6%, which is below the sector norm of approximately 10% to 15%. The company’s net profit for the TTM stood at ₹75 Cr, with a net profit margin of 1.71% in FY 2025. Additionally, the reported return on equity (ROE) is a modest 3.07%, reflecting a potential area for improvement in generating shareholder returns. The interest coverage ratio (ICR) is a robust 8.58x, indicating that the company is well-positioned to meet its interest obligations. However, the cash conversion cycle (CCC) has lengthened significantly to 353 days, suggesting inefficiencies in inventory management and receivable collection that could impact overall profitability.
Balance Sheet Strength and Financial Ratios
Sudarshan Chemical Industries’ balance sheet reflects a total asset base of ₹9,672 Cr, with total borrowings amounting to ₹2,528 Cr. The debt-to-equity ratio stands at 0.60, indicating a moderate level of financial leverage. The company reported reserves of ₹3,504 Cr, which enhances its financial stability and provides a cushion for future growth initiatives. The price-to-book value (P/BV) ratio of 2.26x suggests that the stock is trading at a premium to its book value, which may indicate investor confidence in its long-term prospects. However, the return on capital employed (ROCE) has declined to 6%, highlighting the need for effective capital utilization strategies moving forward.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Sudarshan Chemical Industries reveals a declining trend in promoter holdings, which fell from 35.82% in December 2022 to 8.20% in September 2025, potentially signaling a shift in investor sentiment. Foreign institutional investors (FIIs) hold 8.54%, while domestic institutional investors (DIIs) have increased their stake to 24.17%, reflecting growing institutional interest. The public holds 59.08% of the shares, indicating a broad base of retail investor participation. The total number of shareholders stood at 63,691 as of September 2025. This shift in shareholding dynamics may affect market perceptions and investor confidence, particularly as promoter stakes diminish.
Outlook, Risks, and Final Insight
Looking ahead, Sudarshan Chemical Industries faces a mixed outlook. On one hand, the projected revenue growth and strong interest coverage ratio provide a foundation for optimism. However, the low profitability metrics and lengthening cash conversion cycle present significant risks that could hinder performance. A critical area of focus will be enhancing operational efficiency and managing working capital effectively to improve profit margins. Additionally, the declining promoter stake may lead to concerns about strategic direction and management commitment. The company’s ability to leverage its reserves for growth opportunities while addressing these challenges will be pivotal in shaping its future trajectory in the competitive dyes and pigments sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Dynamic Industries Ltd | 36.8 Cr. | 121 | 190/68.5 | 20.2 | 162 | 0.82 % | 5.68 % | 3.39 % | 10.0 |
| Daikaffil Chemicals India Ltd | 45.8 Cr. | 76.2 | 281/68.5 | 13.2 | 0.00 % | 18.6 % | 18.6 % | 10.0 | |
| Amal Ltd | 833 Cr. | 674 | 1,148/432 | 21.5 | 91.7 | 0.15 % | 36.3 % | 35.0 % | 10.0 |
| Vidhi Specialty Food Ingredients Ltd | 1,687 Cr. | 338 | 570/272 | 35.0 | 62.2 | 1.48 % | 18.7 % | 14.9 % | 1.00 |
| Ushanti Colour Chem Ltd | 60.1 Cr. | 53.5 | 67.1/38.0 | 37.7 | 0.00 % | 0.98 % | 5.98 % | 10.0 | |
| Industry Average | 1,363.62 Cr | 304.17 | 94.26 | 186.93 | 0.39% | 11.00% | 9.10% | 8.13 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 528 | 528 | 691 | 608 | 601 | 566 | 764 | 634 | 696 | 666 | 1,349 | 2,507 | 2,387 |
| Expenses | 486 | 486 | 606 | 538 | 535 | 504 | 645 | 553 | 602 | 587 | 1,222 | 2,314 | 2,255 |
| Operating Profit | 43 | 42 | 85 | 70 | 66 | 62 | 119 | 81 | 94 | 79 | 127 | 192 | 132 |
| OPM % | 8% | 8% | 12% | 11% | 11% | 11% | 16% | 13% | 14% | 12% | 9% | 8% | 6% |
| Other Income | 1 | 1 | 2 | 319 | 6 | 4 | 3 | 4 | -6 | -26 | -38 | 33 | 38 |
| Interest | 9 | 11 | 15 | 10 | 10 | 9 | 8 | 7 | 9 | 11 | 21 | 44 | 44 |
| Depreciation | 27 | 31 | 31 | 35 | 35 | 35 | 36 | 36 | 37 | 37 | 57 | 99 | 97 |
| Profit before tax | 8 | 1 | 41 | 344 | 26 | 22 | 78 | 41 | 43 | 5 | 11 | 82 | 30 |
| Tax % | 43% | 17% | 20% | 22% | 32% | 34% | 26% | 28% | 30% | 89% | 97% | 33% | 35% |
| Net Profit | 5 | 1 | 33 | 267 | 18 | 15 | 58 | 29 | 30 | 1 | 0 | 55 | 19 |
| EPS in Rs | 0.66 | 0.08 | 4.70 | 38.56 | 2.58 | 2.11 | 8.38 | 4.25 | 4.32 | 0.07 | -0.52 | 6.01 | 1.49 |
Last Updated: December 29, 2025, 12:40 am
Below is a detailed analysis of the quarterly data for Sudarshan Chemical Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 2,387.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,507.00 Cr. (Jun 2025) to 2,387.00 Cr., marking a decrease of 120.00 Cr..
- For Expenses, as of Sep 2025, the value is 2,255.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2,314.00 Cr. (Jun 2025) to 2,255.00 Cr., marking a decrease of 59.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 132.00 Cr.. The value appears to be declining and may need further review. It has decreased from 192.00 Cr. (Jun 2025) to 132.00 Cr., marking a decrease of 60.00 Cr..
- For OPM %, as of Sep 2025, the value is 6.00%. The value appears to be declining and may need further review. It has decreased from 8.00% (Jun 2025) to 6.00%, marking a decrease of 2.00%.
- For Other Income, as of Sep 2025, the value is 38.00 Cr.. The value appears strong and on an upward trend. It has increased from 33.00 Cr. (Jun 2025) to 38.00 Cr., marking an increase of 5.00 Cr..
- For Interest, as of Sep 2025, the value is 44.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 44.00 Cr..
- For Depreciation, as of Sep 2025, the value is 97.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 99.00 Cr. (Jun 2025) to 97.00 Cr., marking a decrease of 2.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 30.00 Cr.. The value appears to be declining and may need further review. It has decreased from 82.00 Cr. (Jun 2025) to 30.00 Cr., marking a decrease of 52.00 Cr..
- For Tax %, as of Sep 2025, the value is 35.00%. The value appears to be increasing, which may not be favorable. It has increased from 33.00% (Jun 2025) to 35.00%, marking an increase of 2.00%.
- For Net Profit, as of Sep 2025, the value is 19.00 Cr.. The value appears to be declining and may need further review. It has decreased from 55.00 Cr. (Jun 2025) to 19.00 Cr., marking a decrease of 36.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 1.49. The value appears to be declining and may need further review. It has decreased from 6.01 (Jun 2025) to 1.49, marking a decrease of 4.52.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:35 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,106 | 1,205 | 1,401 | 1,282 | 1,329 | 1,593 | 1,708 | 1,864 | 2,201 | 2,302 | 2,539 | 3,346 | 6,910 |
| Expenses | 974 | 1,075 | 1,232 | 1,093 | 1,139 | 1,386 | 1,460 | 1,574 | 1,923 | 2,088 | 2,220 | 2,962 | 6,380 |
| Operating Profit | 133 | 131 | 170 | 189 | 191 | 207 | 248 | 290 | 278 | 213 | 318 | 383 | 531 |
| OPM % | 12% | 11% | 12% | 15% | 14% | 13% | 15% | 16% | 13% | 9% | 13% | 11% | 8% |
| Other Income | 2 | 23 | 14 | 25 | 15 | 81 | 22 | 7 | 5 | 5 | 332 | -67 | 6 |
| Interest | 43 | 41 | 37 | 30 | 25 | 19 | 16 | 20 | 23 | 44 | 39 | 51 | 120 |
| Depreciation | 37 | 42 | 48 | 49 | 58 | 66 | 74 | 87 | 89 | 114 | 141 | 166 | 290 |
| Profit before tax | 55 | 72 | 99 | 136 | 123 | 203 | 180 | 190 | 171 | 60 | 471 | 99 | 127 |
| Tax % | 37% | 24% | 29% | 25% | 31% | 33% | 20% | 26% | 24% | 25% | 24% | 39% | |
| Net Profit | 35 | 54 | 70 | 101 | 85 | 135 | 145 | 141 | 130 | 45 | 357 | 60 | 75 |
| EPS in Rs | 5.08 | 7.86 | 10.10 | 14.64 | 12.24 | 19.52 | 20.88 | 20.38 | 18.77 | 6.47 | 51.63 | 7.10 | 7.05 |
| Dividend Payout % | 30% | 22% | 30% | 24% | 29% | 31% | 30% | 29% | 27% | 23% | 9% | 63% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 54.29% | 29.63% | 44.29% | -15.84% | 58.82% | 7.41% | -2.76% | -7.80% | -65.38% | 693.33% | -83.19% |
| Change in YoY Net Profit Growth (%) | 0.00% | -24.66% | 14.66% | -60.13% | 74.67% | -51.42% | -10.17% | -5.04% | -57.58% | 758.72% | -776.53% |
Sudarshan Chemical Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 14% |
| 3 Years: | 15% |
| TTM: | 32% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | -11% |
| 3 Years: | -18% |
| TTM: | -35% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 26% |
| 3 Years: | 46% |
| 1 Year: | 36% |
| Return on Equity | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 9% |
| 3 Years: | 6% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 1:36 pm
Balance Sheet
Last Updated: December 4, 2025, 2:02 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 16 | 16 |
| Reserves | 264 | 249 | 300 | 367 | 426 | 554 | 587 | 730 | 819 | 814 | 1,135 | 3,424 | 3,504 |
| Borrowings | 440 | 433 | 430 | 433 | 431 | 367 | 501 | 618 | 823 | 829 | 467 | 2,378 | 2,528 |
| Other Liabilities | 217 | 317 | 346 | 379 | 433 | 424 | 522 | 638 | 705 | 725 | 730 | 3,854 | 3,706 |
| Total Liabilities | 929 | 1,012 | 1,090 | 1,193 | 1,304 | 1,358 | 1,624 | 2,000 | 2,361 | 2,383 | 2,346 | 9,672 | 9,754 |
| Fixed Assets | 327 | 333 | 358 | 452 | 475 | 465 | 627 | 615 | 832 | 1,126 | 1,102 | 2,958 | 3,057 |
| CWIP | 7 | 8 | 15 | 8 | 6 | 24 | 48 | 278 | 285 | 44 | 15 | 140 | 159 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 2 | 2 | 548 | 539 |
| Other Assets | 594 | 671 | 716 | 733 | 822 | 869 | 948 | 1,105 | 1,243 | 1,210 | 1,227 | 6,026 | 5,999 |
| Total Assets | 929 | 1,012 | 1,090 | 1,193 | 1,304 | 1,358 | 1,624 | 2,000 | 2,361 | 2,383 | 2,346 | 9,672 | 9,754 |
Below is a detailed analysis of the balance sheet data for Sudarshan Chemical Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 16.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 16.00 Cr..
- For Reserves, as of Sep 2025, the value is 3,504.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,424.00 Cr. (Mar 2025) to 3,504.00 Cr., marking an increase of 80.00 Cr..
- For Borrowings, as of Sep 2025, the value is 2,528.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 2,378.00 Cr. (Mar 2025) to 2,528.00 Cr., marking an increase of 150.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 3,706.00 Cr.. The value appears to be improving (decreasing). It has decreased from 3,854.00 Cr. (Mar 2025) to 3,706.00 Cr., marking a decrease of 148.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 9,754.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9,672.00 Cr. (Mar 2025) to 9,754.00 Cr., marking an increase of 82.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 3,057.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,958.00 Cr. (Mar 2025) to 3,057.00 Cr., marking an increase of 99.00 Cr..
- For CWIP, as of Sep 2025, the value is 159.00 Cr.. The value appears strong and on an upward trend. It has increased from 140.00 Cr. (Mar 2025) to 159.00 Cr., marking an increase of 19.00 Cr..
- For Investments, as of Sep 2025, the value is 539.00 Cr.. The value appears to be declining and may need further review. It has decreased from 548.00 Cr. (Mar 2025) to 539.00 Cr., marking a decrease of 9.00 Cr..
- For Other Assets, as of Sep 2025, the value is 5,999.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6,026.00 Cr. (Mar 2025) to 5,999.00 Cr., marking a decrease of 27.00 Cr..
- For Total Assets, as of Sep 2025, the value is 9,754.00 Cr.. The value appears strong and on an upward trend. It has increased from 9,672.00 Cr. (Mar 2025) to 9,754.00 Cr., marking an increase of 82.00 Cr..
Notably, the Reserves (3,504.00 Cr.) exceed the Borrowings (2,528.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -307.00 | -302.00 | -260.00 | -244.00 | -240.00 | -160.00 | -253.00 | -328.00 | -545.00 | -616.00 | -149.00 | 381.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 85 | 96 | 92 | 98 | 92 | 79 | 78 | 95 | 83 | 77 | 84 | 134 |
| Inventory Days | 144 | 125 | 113 | 134 | 131 | 119 | 154 | 142 | 163 | 132 | 113 | 507 |
| Days Payable | 63 | 94 | 96 | 139 | 126 | 94 | 139 | 152 | 150 | 136 | 132 | 288 |
| Cash Conversion Cycle | 166 | 127 | 109 | 93 | 96 | 105 | 92 | 85 | 96 | 73 | 65 | 353 |
| Working Capital Days | 41 | 26 | 40 | 14 | 43 | 51 | 24 | 29 | 18 | 23 | 40 | 154 |
| ROCE % | 14% | 16% | 19% | 22% | 18% | 17% | 18% | 17% | 13% | 6% | 11% | 6% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| HDFC Small Cap Fund | 5,789,852 | 1.54 | 586.69 | N/A | N/A | N/A |
| Tata Small Cap Fund | 4,691,125 | 4.17 | 475.35 | N/A | N/A | N/A |
| Axis Small Cap Fund | 1,945,414 | 0.74 | 197.13 | 2,440,688 | 2025-12-08 01:00:56 | -20.29% |
| Franklin India Opportunities Fund | 1,431,787 | 1.75 | 145.08 | N/A | N/A | N/A |
| Nippon India Small Cap Fund | 1,083,578 | 0.16 | 109.8 | N/A | N/A | N/A |
| Tata Large & Mid Cap Fund | 1,080,011 | 1.25 | 109.44 | 973,769 | 2025-12-15 00:29:34 | 10.91% |
| DSP Small Cap Fund | 640,000 | 0.38 | 64.85 | N/A | N/A | N/A |
| Bandhan Small Cap Fund | 25,000 | 0.01 | 2.53 | N/A | N/A | N/A |
| ICICI Prudential Commodities Fund | 14,788 | 0.05 | 1.5 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 7.90 | 51.60 | 6.50 | 18.80 | 20.40 |
| Diluted EPS (Rs.) | 7.90 | 51.60 | 6.50 | 18.70 | 20.40 |
| Cash EPS (Rs.) | 28.45 | 72.03 | 22.97 | 31.67 | 32.88 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 437.80 | 165.99 | 119.64 | 120.36 | 107.41 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 437.80 | 165.99 | 119.64 | 120.36 | 107.41 |
| Revenue From Operations / Share (Rs.) | 425.78 | 366.74 | 332.50 | 317.92 | 269.28 |
| PBDIT / Share (Rs.) | 52.74 | 48.18 | 31.12 | 40.42 | 42.58 |
| PBIT / Share (Rs.) | 31.59 | 27.78 | 14.62 | 27.53 | 30.08 |
| PBT / Share (Rs.) | 12.26 | 67.97 | 8.63 | 24.72 | 27.50 |
| Net Profit / Share (Rs.) | 7.29 | 51.64 | 6.47 | 18.77 | 20.38 |
| NP After MI And SOA / Share (Rs.) | 7.10 | 51.64 | 6.47 | 18.77 | 20.38 |
| PBDIT Margin (%) | 12.38 | 13.13 | 9.35 | 12.71 | 15.81 |
| PBIT Margin (%) | 7.41 | 7.57 | 4.39 | 8.65 | 11.17 |
| PBT Margin (%) | 2.87 | 18.53 | 2.59 | 7.77 | 10.21 |
| Net Profit Margin (%) | 1.71 | 14.07 | 1.94 | 5.90 | 7.56 |
| NP After MI And SOA Margin (%) | 1.66 | 14.07 | 1.94 | 5.90 | 7.56 |
| Return on Networth / Equity (%) | 1.62 | 31.10 | 5.40 | 15.59 | 18.97 |
| Return on Capital Employeed (%) | 3.64 | 12.88 | 7.23 | 14.59 | 18.20 |
| Return On Assets (%) | 0.57 | 15.17 | 1.87 | 5.48 | 7.04 |
| Long Term Debt / Equity (X) | 0.47 | 0.16 | 0.54 | 0.44 | 0.41 |
| Total Debt / Equity (X) | 0.60 | 0.38 | 0.98 | 0.98 | 0.65 |
| Asset Turnover Ratio (%) | 0.55 | 1.07 | 0.87 | 0.90 | 0.96 |
| Current Ratio (X) | 2.12 | 1.38 | 1.17 | 1.13 | 1.20 |
| Quick Ratio (X) | 1.27 | 0.87 | 0.67 | 0.60 | 0.72 |
| Inventory Turnover Ratio (X) | 2.31 | 5.45 | 2.48 | 2.82 | 2.64 |
| Dividend Payout Ratio (NP) (%) | 12.41 | 9.87 | 77.31 | 31.95 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 3.11 | 7.08 | 21.77 | 18.94 | 0.00 |
| Earning Retention Ratio (%) | 87.59 | 90.13 | 22.69 | 68.05 | 0.00 |
| Cash Earning Retention Ratio (%) | 96.89 | 92.92 | 78.23 | 81.06 | 0.00 |
| Interest Coverage Ratio (X) | 8.58 | 9.04 | 5.19 | 14.41 | 16.49 |
| Interest Coverage Ratio (Post Tax) (X) | 4.33 | 2.15 | 2.08 | 7.69 | 8.90 |
| Enterprise Value (Cr.) | 8962.37 | 4605.33 | 3488.90 | 4384.53 | 4055.41 |
| EV / Net Operating Revenue (X) | 2.68 | 1.81 | 1.52 | 1.99 | 2.18 |
| EV / EBITDA (X) | 21.63 | 13.81 | 16.19 | 15.67 | 13.76 |
| MarketCap / Net Operating Revenue (X) | 2.33 | 1.66 | 1.17 | 1.64 | 1.93 |
| Retention Ratios (%) | 87.58 | 90.12 | 22.68 | 68.04 | 0.00 |
| Price / BV (X) | 2.26 | 3.67 | 3.26 | 4.32 | 4.83 |
| Price / Net Operating Revenue (X) | 2.33 | 1.66 | 1.17 | 1.64 | 1.93 |
| EarningsYield | 0.01 | 0.08 | 0.01 | 0.03 | 0.03 |
After reviewing the key financial ratios for Sudarshan Chemical Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 7.90. This value is within the healthy range. It has decreased from 51.60 (Mar 24) to 7.90, marking a decrease of 43.70.
- For Diluted EPS (Rs.), as of Mar 25, the value is 7.90. This value is within the healthy range. It has decreased from 51.60 (Mar 24) to 7.90, marking a decrease of 43.70.
- For Cash EPS (Rs.), as of Mar 25, the value is 28.45. This value is within the healthy range. It has decreased from 72.03 (Mar 24) to 28.45, marking a decrease of 43.58.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 437.80. It has increased from 165.99 (Mar 24) to 437.80, marking an increase of 271.81.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 437.80. It has increased from 165.99 (Mar 24) to 437.80, marking an increase of 271.81.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 425.78. It has increased from 366.74 (Mar 24) to 425.78, marking an increase of 59.04.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 52.74. This value is within the healthy range. It has increased from 48.18 (Mar 24) to 52.74, marking an increase of 4.56.
- For PBIT / Share (Rs.), as of Mar 25, the value is 31.59. This value is within the healthy range. It has increased from 27.78 (Mar 24) to 31.59, marking an increase of 3.81.
- For PBT / Share (Rs.), as of Mar 25, the value is 12.26. This value is within the healthy range. It has decreased from 67.97 (Mar 24) to 12.26, marking a decrease of 55.71.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 7.29. This value is within the healthy range. It has decreased from 51.64 (Mar 24) to 7.29, marking a decrease of 44.35.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 7.10. This value is within the healthy range. It has decreased from 51.64 (Mar 24) to 7.10, marking a decrease of 44.54.
- For PBDIT Margin (%), as of Mar 25, the value is 12.38. This value is within the healthy range. It has decreased from 13.13 (Mar 24) to 12.38, marking a decrease of 0.75.
- For PBIT Margin (%), as of Mar 25, the value is 7.41. This value is below the healthy minimum of 10. It has decreased from 7.57 (Mar 24) to 7.41, marking a decrease of 0.16.
- For PBT Margin (%), as of Mar 25, the value is 2.87. This value is below the healthy minimum of 10. It has decreased from 18.53 (Mar 24) to 2.87, marking a decrease of 15.66.
- For Net Profit Margin (%), as of Mar 25, the value is 1.71. This value is below the healthy minimum of 5. It has decreased from 14.07 (Mar 24) to 1.71, marking a decrease of 12.36.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.66. This value is below the healthy minimum of 8. It has decreased from 14.07 (Mar 24) to 1.66, marking a decrease of 12.41.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.62. This value is below the healthy minimum of 15. It has decreased from 31.10 (Mar 24) to 1.62, marking a decrease of 29.48.
- For Return on Capital Employeed (%), as of Mar 25, the value is 3.64. This value is below the healthy minimum of 10. It has decreased from 12.88 (Mar 24) to 3.64, marking a decrease of 9.24.
- For Return On Assets (%), as of Mar 25, the value is 0.57. This value is below the healthy minimum of 5. It has decreased from 15.17 (Mar 24) to 0.57, marking a decrease of 14.60.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.47. This value is within the healthy range. It has increased from 0.16 (Mar 24) to 0.47, marking an increase of 0.31.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.60. This value is within the healthy range. It has increased from 0.38 (Mar 24) to 0.60, marking an increase of 0.22.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.55. It has decreased from 1.07 (Mar 24) to 0.55, marking a decrease of 0.52.
- For Current Ratio (X), as of Mar 25, the value is 2.12. This value is within the healthy range. It has increased from 1.38 (Mar 24) to 2.12, marking an increase of 0.74.
- For Quick Ratio (X), as of Mar 25, the value is 1.27. This value is within the healthy range. It has increased from 0.87 (Mar 24) to 1.27, marking an increase of 0.40.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.31. This value is below the healthy minimum of 4. It has decreased from 5.45 (Mar 24) to 2.31, marking a decrease of 3.14.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 12.41. This value is below the healthy minimum of 20. It has increased from 9.87 (Mar 24) to 12.41, marking an increase of 2.54.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 3.11. This value is below the healthy minimum of 20. It has decreased from 7.08 (Mar 24) to 3.11, marking a decrease of 3.97.
- For Earning Retention Ratio (%), as of Mar 25, the value is 87.59. This value exceeds the healthy maximum of 70. It has decreased from 90.13 (Mar 24) to 87.59, marking a decrease of 2.54.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 96.89. This value exceeds the healthy maximum of 70. It has increased from 92.92 (Mar 24) to 96.89, marking an increase of 3.97.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 8.58. This value is within the healthy range. It has decreased from 9.04 (Mar 24) to 8.58, marking a decrease of 0.46.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.33. This value is within the healthy range. It has increased from 2.15 (Mar 24) to 4.33, marking an increase of 2.18.
- For Enterprise Value (Cr.), as of Mar 25, the value is 8,962.37. It has increased from 4,605.33 (Mar 24) to 8,962.37, marking an increase of 4,357.04.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.68. This value is within the healthy range. It has increased from 1.81 (Mar 24) to 2.68, marking an increase of 0.87.
- For EV / EBITDA (X), as of Mar 25, the value is 21.63. This value exceeds the healthy maximum of 15. It has increased from 13.81 (Mar 24) to 21.63, marking an increase of 7.82.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.33. This value is within the healthy range. It has increased from 1.66 (Mar 24) to 2.33, marking an increase of 0.67.
- For Retention Ratios (%), as of Mar 25, the value is 87.58. This value exceeds the healthy maximum of 70. It has decreased from 90.12 (Mar 24) to 87.58, marking a decrease of 2.54.
- For Price / BV (X), as of Mar 25, the value is 2.26. This value is within the healthy range. It has decreased from 3.67 (Mar 24) to 2.26, marking a decrease of 1.41.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.33. This value is within the healthy range. It has increased from 1.66 (Mar 24) to 2.33, marking an increase of 0.67.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.08 (Mar 24) to 0.01, marking a decrease of 0.07.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Sudarshan Chemical Industries Ltd:
- Net Profit Margin: 1.71%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 3.64% (Industry Average ROCE: 11%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.62% (Industry Average ROE: 9.1%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.33
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.27
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 73.5 (Industry average Stock P/E: 94.26)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.6
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.71%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Dyes & Pigments | 7th Floor, Eleven West Panchshil, Pune Maharashtra 411045 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Rajesh B Rathi | Chairman & Managing Director |
| Mr. Ashish Vij | Whole Time Director |
| Mr. Naresh T Raisinghani | Ind. Non-Executive Director |
| Mrs. Shubhalakshmi A Panse | Ind. Non-Executive Director |
| Mrs. Anu A Wakhlu | Ind. Non-Executive Director |
| Mrs. Sudha P Navandar | Ind. Non-Executive Director |
| Ms. Bhumika Batra | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Sudarshan Chemical Industries Ltd?
Sudarshan Chemical Industries Ltd's intrinsic value (as of 05 January 2026) is ₹812.51 which is 15.36% lower the current market price of ₹960.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹7,546 Cr. market cap, FY2025-2026 high/low of ₹1,604/796, reserves of ₹3,504 Cr, and liabilities of ₹9,754 Cr.
What is the Market Cap of Sudarshan Chemical Industries Ltd?
The Market Cap of Sudarshan Chemical Industries Ltd is 7,546 Cr..
What is the current Stock Price of Sudarshan Chemical Industries Ltd as on 05 January 2026?
The current stock price of Sudarshan Chemical Industries Ltd as on 05 January 2026 is ₹960.
What is the High / Low of Sudarshan Chemical Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Sudarshan Chemical Industries Ltd stocks is ₹1,604/796.
What is the Stock P/E of Sudarshan Chemical Industries Ltd?
The Stock P/E of Sudarshan Chemical Industries Ltd is 73.5.
What is the Book Value of Sudarshan Chemical Industries Ltd?
The Book Value of Sudarshan Chemical Industries Ltd is 448.
What is the Dividend Yield of Sudarshan Chemical Industries Ltd?
The Dividend Yield of Sudarshan Chemical Industries Ltd is 0.47 %.
What is the ROCE of Sudarshan Chemical Industries Ltd?
The ROCE of Sudarshan Chemical Industries Ltd is 6.03 %.
What is the ROE of Sudarshan Chemical Industries Ltd?
The ROE of Sudarshan Chemical Industries Ltd is 3.07 %.
What is the Face Value of Sudarshan Chemical Industries Ltd?
The Face Value of Sudarshan Chemical Industries Ltd is 2.00.